Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Inorganic Biochemistry|June 3, 2025
Potent mitochondria-targeting rutheniumII and iridiumIII anticancer complexes containing hybrid N^NH-chelated ligandsHeqian Dong, Hanxiu Fu, Kangning Lai, et al.Inorganic Chemistry|December 16, 2024
Triphenylphosphine-Modified IridiumIII, RhodiumIII, and RutheniumII Complexes to Achieve Enhanced Anticancer Selectivity by Targeting MitochondriaZhe Liu, Hanxiu Fu, Heqian Dong, et al.Bioorganic Chemistry|January 12, 2025
Triphenylphosphine-modified cyclometalated iridiumIII complexes as mitochondria-targeting anticancer agents with enhanced selectivityHanxiu Fu, Shuli Wang, Yuwen Gong, et al.Dalton Transactions (Cambridge, England : 2003)|January 11, 2024
Mitochondria-targeted neutral and cationic iridium(III) anticancer complexes chelating simple hybrid sp2-N/sp3-N donor ligandsPengwei Li, Lihua Guo, Jiaxing Li, et al.Inorganic Chemistry|February 3, 2025
Enhanced Anticancer Selectivity of Cyclometalated Imidazole/Pyrazole-Imine IridiumIII Complexes Through the Switch from Cationic to Zwitterionic FormsZhe Liu, Kangning Lai, Pengwei Li, et al.Journal of Inorganic Biochemistry|June 6, 2024
Iminoamido chelated iridium(III) and ruthenium(II) anticancer complexes with mitochondria-targeting ability and potential to overcome cisplatin resistanceLihua Guo, Pengwei Li, Zhihong Jing, et al.Inorganic Chemistry|May 17, 2025
Systematic Investigation of Coordination Chemistry in Iridium(III) and Ruthenium(II) Complexes Derived from Pyridyl-Amine Ligands and Their Anticancer EvaluationLihua Guo, Zhihao Yang, Heqian Dong, et al.Pageof 1